Managers / Q1 2023 · view latest →
ION Acquisition Corp GP Ltd.
CIK 0001844573 · 89 MEDINAT HAYEHUDIM, HERZLIYA, L3, 4676672 · 972 (9) 970-3620
Summary
Ion Acquisition Corp GP Ltd. reported $17,070 in U.S.-listed holdings across 4 positions for Q1 2023.
The portfolio is heavily concentrated: Innovid alone accounts for 51.6% of reported value.
The book was largely unchanged from Q4 2022.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 100.0% · $17,070
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TABOOLA.COM LTD | TRIMMED | −3.21M | 1.92M | −$10,568 | $5,235 |
| TABOOLA.COM LTD W | HELD | −6.6K | 5.65M | −$458 | $2,316 |
| INNOVID CORP W | HELD | +0 | 7.06M | −$2,118 | $706 |
| INNOVID CORP | HELD | +0 | 6.25M | −$1,875 | $8,813 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | INNOVID CORP | COMMON STOCK | 51.63% | $8,813 | 6.25M |
| 2 | TABOOLA.COM LTD | ORD SHS | 30.67% | $5,235 | 1.92M |
| 3 | TABOOLA.COM LTD W | *W EXP 06/29/202 | 13.57% | $2,316 | 5.65M |
| 4 | INNOVID CORP W | *W EXP 11/30/202 | 4.14% | $706 | 7.06M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $6M | 3 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $4,673 | 4 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $17,070 | 4 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 4 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $103M | 5 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $97M | 5 | Aug 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $149M | 5 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $172M | 5 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.